This Solicitation opportunity from Florida was posted on August 1, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Emergency Opiod Antagonist Products and Resources

Closed

RFP-13519State & Local

Submission Closed11/10/2025, 12:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Norethindrone and Ethinyl Estradiol Tablets SupplierThis subcontract involves the supply of FDA-regulated Norethindrone and Ethinyl Estradiol Tablets, USP, to support prime contractors on Department of Defense Medical Supply Chain projects. The supplier is responsible for manufacturing or sourcing tablets that adhere to USP standards, with each package organized into six cycles of 28 tablets. A total of 12 pharmaceutical tablet packages are required for delivery. To ensure compliance, all products must be produced in FDA-approved facilities. Packaging must strictly follow MIL-STD-2073-1E and Medical Marking Standard No. 1. This opportunity falls under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing of Emollient LotionThis subcontract involves the pharmaceutical manufacturing of emollient lotion for prime contractors supporting Department of Defense medical supply contracts. The scope of work requires the formulation and blending of non-sterile, homogeneous oil-in-water or water-in-oil emulsion lotions using industrial emulsification equipment. The final product must adhere to strict technical specifications, including a pH range of 5.0 to 8.1 and a viscosity between 10,000 and 20,000 CPS, while meeting NSN 6508010197181 standards. The contractor is responsible for blending water, oils, emulsifiers, and preservatives, as well as maintaining controlled room temperature storage for the materials. Deliverables may be provided in bulk or bottled formats. This opportunity is managed by the Medical Supply Chain Pharm FSA under NAICS code 325412, with the place of performance located at FPO 96607.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Acetone Test Tablet SupplierThis subcontract involves the supply of FDA-regulated Acetone Test Tablets for prime contractors supporting the Department of Defense Medical Supply Chain. The required tablets must feature a 5 mg/dL sensitivity for acetoacetic acid and ensure no reaction with beta-hydroxybutyric acid. Each order consists of one bottle containing 100 tablets under NSN 6550016666950, with strict adherence to MIL-STD-2073-1E and Medical Marking Standard No. 1 for packaging. The supplier is responsible for managing an 18-month shelf life, ensuring that all products are delivered within three months of their manufacture date. This procurement falls under NAICS code 325412 and is managed by the Medical Supply Chain MD SURG FSF. Performance for this contract is centered in APO 96260-5479.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Chlorine Dioxide Water Purification TabletsThis subcontract involves the supply of stabilized chlorine dioxide water purification tablets to prime contractors supporting Department of Defense medical supply contracts through the Medical Supply Chain Pharm FSA. The requirement is for 100 packages of sealed tablets, with each package containing 10 individually sealed units. To ensure compliance, the tablets must contain no active chlorine or iodine and must strictly adhere to military specifications for first aid kit components under NSN 6850-01-530-3396. The procurement falls under NAICS code 325412 and is designated for performance at APO 96260-5479. Interested parties must submit their responses by the deadline of November 2, 2026, following the solicitation posted on October 27, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Omeprazole Extended-Release Capsules SupplyThis subcontract involves the supply of FDA-regulated Omeprazole Extended-Release Capsules for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The provider is responsible for manufacturing or sourcing 20 mg delayed release capsules that adhere to NSN 6505-01-624-7068, ensuring a minimum remaining shelf life of 21 months. The contract requires the delivery of 17 bottles of medication, with packaging and labeling strictly following ASTM D3951 and Medical Marking Standard No. 1. To be eligible, the supplier must maintain active FDA registration and ensure full compliance with the Buy American Act. The performance of this contract is centered at Fort Bragg, with a response deadline set for November 2, 2026. This procurement falls under NAICS code 325412, focusing on the specialized production and distribution of pharmaceutical preparations.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Kerlix Gauze Bandages (NSN 6510-00-058-3047)This subcontract involves the supply of white, rubberless, crimped, and stretchable Kerlix gauze bandages for prime contractors supporting Department of Defense Medical Supply Chain projects. The required bandages must measure 4.5 inches by 4 yards, be individually sealed, and be packaged in units of 100. All products must be manufactured or sourced in compliance with the Buy American Act and delivered FOB Destination to San Antonio, Texas. Strict adherence to quality and logistics standards is required, specifically MIL-STD-2073-1E, MIL-STD-129, and Medical Marking Standard No. 1 for all labeling and packaging. The contract falls under NAICS code 325412 and is managed by the Medical Supply Chain MD SURG FSF. Interested parties must respond by November 2, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0189

Solicitation SPE2DP-27-T-0189 is a procurement request by the Defense Logistics Agency for Norethindrone and Ethinyl Estradiol Tablets, USP, identified by NSN 6505015062659. The requirement consists of multiple line items, including quantities of 3, 6, and 3 packages. Each package contains 168 tablets organized into six cycles of 28 tablets, with specific active ingredient dosages and inert tablets. The product is FDA regulated and must be stored at 25 degrees Celsius, with a non-extendable shelf life of 36 months. Delivery is required within five days after receipt of order, with FOB Destination terms, including a specific delivery location at Kadena Air Base in Okinawa, Japan. Compliance requires adherence to Medical Marking Standard No. 1 and MIL-STD-2073-1E for packaging and preservation. Items must be shipped in sealed unit containers within commercial exterior shipping containers. Inspection and acceptance will occur at the destination per FAR 52.246-2. The contract incorporates various federal and defense clauses, including the Buy American Act, safeguarding of covered defense information under DFARS 252.204-7012, and electronic invoicing via the Wide Area WorkFlow system. Offerors must be registered in the System for Award Management and comply with NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

HYDROXYPROPYL METHYLCE

Solicitation # SPE2DP-27-T-0185

Solicitation SPE2DP-27-T-0185 is a Small Business Set-Aside request for the procurement of Ocucoat Viscoelastic 1ML, a 2% hydroxypropyl methylcellulose ophthalmic solution (NSN 6505016331037). This FDA-regulated medical device is designed for high-volume, small-incision cataract surgery and lens inserter lubrication. The requirement consists of 5 boxes, with a delivery timeline of 79 days after receipt of order and an original required delivery date of October 27, 2026. Delivery is FOB Destination, with the final destination located at the USA Med Mat Ctr EUR in Kaiserslautern, Germany. The contract mandates strict quality and shelf-life compliance, requiring a non-extendable shelf life of 24 months per RS016. Packaging must be commercial and sealed to prevent damage, adhering to MIL-STD-2073-1E and DLA packaging requirements. Marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must include the National Stock Number, manufacturer date, expiration or retest date, contract number, and lot number. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and payment. The procurement is subject to various DFARS and FAR clauses, including the Buy American Act, safeguarding of covered defense information, and prohibitions on certain telecommunications equipment.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0186

Solicitation SPE2DP-27-T-0186, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of one bottle of Enrofloxacin Tablets (NSN 6509-01-487-5834). The medication is specified as 68 mg with a 7% concentration for veterinary use in dogs and cats, providing broad-spectrum antibacterial activity. The item is designated as Type I (Code Q) with a non-extendable shelf life of 36 months and must be stored at controlled room temperature. Delivery is required within 84 days after the date of order, with shipping terms set as FOB Destination to a facility in Kaiserslautern, Germany. The contract mandates strict adherence to quality and packaging standards, including MIL-STD-2073-1E, MIL-STD-129, and Medical Marking Standard No. 1. Special packaging instructions MPPWN00001 apply, and hazardous materials must be labeled according to the Hazard Communication Standard 29 CFR 1910.1200. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and payment. The procurement is subject to the Buy American and Balance of Payments Program (DFARS 252.225-7001) and requires compliance with cybersecurity reporting under DFARS 252.204-7012. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0188

Solicitation SPE2DP-27-T-0188 is a procurement for emollient lotion under NAICS code 325412, managed by the Defense Logistics Agency. The requirement consists of multiple line items, including 500 bottles for CLIN 0001 and 12 bottles for CLIN 0002, with an additional 250 bottles for CLIN 0003. The product must be a non-sterile, homogeneous oil-in-water or water-in-oil emulsion with a pH range between 5.0 and 8.1 and a viscosity of 10,000 to 20,000 CPS. Each unit consists of a 240 ML (8 FL OZ) bottle equipped with a dispenser cap. The lotion must contain water, a suitable oil, an emulsifier, and a preservative, and it must be stored at controlled room temperature. Delivery is required within 20 days after the order, with specific required delivery dates ranging from June 17, 2026, to July 20, 2026. Shipments are designated as FOB Destination to various locations, including the USS George Washington, USS Iwo Jima, and the USNS Mercy. Packaging must comply with MIL-STD-129 and Medical Marking Standard No. 1, with non-hazardous materials following ASTM D3951 and hazardous materials adhering to TQ requirement IP025 and FED-STD-313. Palletization must follow DLA requirement RP001. The contract incorporates various FAR and DFARS clauses, including the Buy American Act, Wide Area Workflow for electronic payments, and destination inspection requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing and SupplyThis subcontract for Pharmaceutical Manufacturing and Supply involves the production and delivery of specialized pharmaceutical preparations for prime contractors supporting the Department of Veterans Affairs. The scope of work encompasses the entire manufacturing lifecycle, including the compounding of pharmaceuticals, rigorous quality control testing, packaging, and labeling, with final delivery to VA facilities. To qualify, providers must maintain pharmaceutical grade manufacturing facilities and clean rooms, ensuring full FDA approval and strict adherence to current Good Manufacturing Practice compliance. This opportunity is managed under the Department of Veterans Affairs Network Contract Office 22 and is categorized under NAICS code 325412.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

6505--VA Long Beach Pylarify

Solicitation # 36C26227Q0072

The Department of Veterans Affairs Long Beach Healthcare System intends to award a sole source, firm-fixed-price delivery order for Pylarify (piflufolastat F18) radiopharmaceutical injections. This advanced diagnostic imaging agent is utilized by the Nuclear Medicine department in conjunction with PET/CT scans to identify prostate-specific membrane antigen (PSMA) in prostate tumors, lymph nodes, bones, and other organs. The procurement is categorized under NAICS code 325412, Pharmaceutical Preparation Manufacturing, which has a size standard of 1,300 employees. The government has identified Progenics Pharmaceuticals, Inc. as the intended contractor, as the product is available under the VA National Acquisition Center Contract Federal Supply Schedule 36F79725D0093, effective from April 1, 2025, through March 31, 2030. This action is being conducted in accordance with RFO Part 8.401 and GSAM/R 538.7104-3(b)(ii) and 538.7104-4 regarding items peculiar to one manufacturer. While this is not a formal solicitation, interested parties capable of providing the same items may submit a capabilities statement to Contracting Specialist Melissa Ramirez by November 3, 2026, at 10:00 AM Pacific Local Time.

262-NETWORK Contract Office 22 (36C262)

POSTED

1 day ago

DEADLINE

in 6 days

General Info

Agency

Florida Department of Children and Families (DCF)

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

FL, USA

Set-Aside

NONE

Documents

Addendum No. 01 to DCF RFP 2526 018 Emergency Opioid Antagonist Products & Resources

2 pages · amendment

High

DCF RFP 2526 018 Emergency Opioid Antagonist Products & Resources

22 pages · rfp

High

PO SOW DCF Overdose Prevention Program RFP 2526 018 v18

10 pages · sow

High

DCF Purchase Order Terms and Conditions PMT-47-2021

13 pages · contract-document

Low

AI Contract Breakdown

Uniform Contract Format

Timeline

2 updates

PhaseClosed

PostedAug 1

Solicitation

Notice updatedAug 1

The notice title changed. NAICS code changed from 621330 to 325412. The notice description changed.

Notice updatedAug 1

The notice title changed.

Response DeadlineNov 10

Deadline has passed

Submission Closed

11/10/2025, 12:00:00 AM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyFlorida Department of Children and Families (DCF)

Contacts1 person available

OfficeN/A

Organization / AgencyFlorida Department of Children and Families (DCF)

Office AddressN/A

Contacts

Sally Johns

contact@example.gov

+1 (555) 000-0000

Full Description

In accordance with Chapter 287, Florida Statutes (F.S.), the State of Florida, Department of Children and Families (Department), Substance Abuse and Mental Health (SAMH) issues this Request for Proposals (RFP) for providers to supply the Florida Department of Children and Families’ Overdose Prevention Program with multiple formulations of Emergency Opioid Antagonist Products and Resources. The Overdose Prevention Program aims to provide Overdose Recognition and Response Training and distribute free naloxone kits to individuals in the community at risk of experiencing or witnessing an opioid overdose. The selected Respondent must be able to provide all products and services awarded on day one of the Contract. There is no ramp up period.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS